Literature DB >> 19375581

Different pathophysiology of impaired glucose tolerance in first-degree relatives of individuals with type 2 diabetes mellitus.

Peter Emerson1, Timon W Van Haeften, Walkyria Pimenta, Elena Plummer, Hans J Woerle, Asimina Mitrakou, Ervin Szoke, John Gerich, Christian Meyer.   

Abstract

To assess whether an increased genetic predisposition for type 2 diabetes mellitus (T2DM) influences the contributions of insulin resistance and impaired insulin secretion to impaired glucose tolerance (IGT), 437 subjects not known to have T2DM underwent an oral glucose tolerance test and a 3-hour hyperglycemic clamp. Plasma insulin responses and insulin sensitivity were compared between all subjects (unselected for demographic or anthropometric characteristics) who had normal glucose homeostasis and no first-degree T2DM relative (n = 133), IGT with a first-degree T2DM relative (IGT/FH+, n = 74), or IGT without a first-degree T2DM relative (IGT/FH-, n = 50). Compared with those with normal glucose homeostasis, first- and second-phase plasma insulin responses were reduced approximately 45% and 30%, respectively (both P < .001), in IGT/FH+, whereas insulin sensitivity was only approximately 20% reduced (P = .011). In contrast, in IGT/FH-, first-phase plasma insulin responses were only approximately 20% reduced (P = .016), second-phase plasma insulin responses were not reduced, but insulin sensitivity was approximately 40% reduced (P < .001). The IGT/FH+ group differed significantly from the IGT/FH- group by having 25% to 30% lower first-phase plasma insulin responses (P = .026) and 25% to 30% greater insulin sensitivity (P = .027). Adjustment for obesity abolished the differences in insulin resistance but not plasma insulin responses. However, when the IGT groups were stratified into subgroups based on body mass index (BMI), first-phase plasma insulin responses were approximately 30% lower in IGT/FH+ with a BMI of at least 27 kg/m(2) (P = .018) but similar in IGT/FH+ with a BMI less than 27 kg/m(2) compared with the corresponding IGT/FH- subgroups. We conclude that, in IGT, an increased genetic predisposition for T2DM increases the contribution of impaired insulin secretion to its pathophysiology. This effect is enhanced by obesity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19375581      PMCID: PMC2713184          DOI: 10.1016/j.metabol.2008.12.004

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  23 in total

Review 1.  Follow-up report on the diagnosis of diabetes mellitus.

Authors:  Saul Genuth; K G M M Alberti; Peter Bennett; John Buse; Ralph Defronzo; Richard Kahn; John Kitzmiller; William C Knowler; Harold Lebovitz; Ake Lernmark; David Nathan; Jerry Palmer; Robert Rizza; Christopher Saudek; Jonathan Shaw; Michael Steffes; Michael Stern; Jaako Tuomilehto; Paul Zimmet
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

2.  Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

Authors:  S E Kahn; R L Prigeon; D K McCulloch; E J Boyko; R N Bergman; M W Schwartz; J L Neifing; W K Ward; J C Beard; J P Palmer
Journal:  Diabetes       Date:  1993-11       Impact factor: 9.461

3.  Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man.

Authors:  N N Abumrad; D Rabin; M P Diamond; W W Lacy
Journal:  Metabolism       Date:  1981-09       Impact factor: 8.694

4.  Relative conributions of beta-cell function and tissue insulin sensitivity to fasting and postglucose-load glycemia.

Authors:  T W van Haeften; W Pimenta; A Mitrakou; M Korytkowski; T Jenssen; H Yki-Jarvinen; J E Gerich
Journal:  Metabolism       Date:  2000-10       Impact factor: 8.694

5.  Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes.

Authors:  Kenneth Cusi; Sangeeta Kashyap; Amalia Gastaldelli; Mandeep Bajaj; Eugenio Cersosimo
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-02-13       Impact factor: 4.310

6.  A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.

Authors:  Sangeeta Kashyap; Renata Belfort; Amalia Gastaldelli; Thongchai Pratipanawatr; Rachele Berria; Wilailak Pratipanawatr; Mandeep Bajaj; Lawrence Mandarino; Ralph DeFronzo; Kenneth Cusi
Journal:  Diabetes       Date:  2003-10       Impact factor: 9.461

7.  Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Authors:  R A DeFronzo; J D Tobin; R Andres
Journal:  Am J Physiol       Date:  1979-09

8.  Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values.

Authors:  Hans J Woerle; Walkyria P Pimenta; Christian Meyer; Niyaz R Gosmanov; Ervin Szoke; Tamas Szombathy; Asimina Mitrakou; John E Gerich
Journal:  Arch Intern Med       Date:  2004 Aug 9-23

Review 9.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.

Authors:  S E Kahn
Journal:  Diabetologia       Date:  2003-01-11       Impact factor: 10.122

10.  Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes.

Authors:  S P O'Rahilly; Z Nugent; A S Rudenski; J P Hosker; M A Burnett; P Darling; R C Turner
Journal:  Lancet       Date:  1986-08-16       Impact factor: 79.321

View more
  5 in total

Review 1.  Dynamics of insulin secretion and the clinical implications for obesity and diabetes.

Authors:  Susumu Seino; Tadao Shibasaki; Kohtaro Minami
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

2.  Comparison of area under the curve in various models of diabetic rats receiving chronic medication.

Authors:  Keng-Fan Liu; Chiang-Shan Niu; Jen-Chieh Tsai; Chao-Lin Yang; Wen-Huang Peng; Ho-Shan Niu
Journal:  Arch Med Sci       Date:  2020-01-07       Impact factor: 3.707

3.  Family history of diabetes, lifestyle factors, and the 7-year incident risk of type 2 diabetes mellitus in middle-aged Japanese men and women.

Authors:  Masaru Sakurai; Koshi Nakamura; Katsuyuki Miura; Toshinari Takamura; Katsushi Yoshita; Satoshi Sasaki; Shin-Ya Nagasawa; Yuko Morikawa; Masao Ishizaki; Teruhiko Kido; Yuchi Naruse; Yasushi Suwazono; Hideaki Nakagawa
Journal:  J Diabetes Investig       Date:  2013-02-13       Impact factor: 4.232

4.  Glucose-dependent phosphorylation signaling pathways and crosstalk to mitochondrial respiration in insulin secreting cells.

Authors:  Jaime Santo-Domingo; Antonio Núñez Galindo; Ornella Cominetti; Umberto De Marchi; Pedro Cutillas; Loïc Dayon; Andreas Wiederkehr
Journal:  Cell Commun Signal       Date:  2019-02-20       Impact factor: 5.712

5.  Impact of A Cargo-Less Liposomal Formulation on Dietary Obesity-Related Metabolic Disorders in Mice.

Authors:  Varsha Komalla; Behjat Sheikholeslami; Gerard Li; Bishwajit Bokshi; Yik Lung Chan; Alison Ung; Brian Gregory Oliver; Hui Chen; Mehra Haghi
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.